

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | fatty acid elongation (GO:0030497) | 6.95866157 |
| 2 | long-chain fatty acid biosynthetic process (GO:0042759) | 6.43382528 |
| 3 | ensheathment of neurons (GO:0007272) | 5.96734473 |
| 4 | axon ensheathment (GO:0008366) | 5.96734473 |
| 5 | myelination (GO:0042552) | 5.95880853 |
| 6 | pyrimidine nucleobase catabolic process (GO:0006208) | 5.83273038 |
| 7 | postsynaptic membrane organization (GO:0001941) | 5.31607352 |
| 8 | negative regulation of neurotransmitter transport (GO:0051589) | 5.09813518 |
| 9 | negative regulation of neurotransmitter secretion (GO:0046929) | 4.69326435 |
| 10 | regulation of collateral sprouting (GO:0048670) | 4.49724179 |
| 11 | nucleobase catabolic process (GO:0046113) | 4.40375667 |
| 12 | synaptic vesicle maturation (GO:0016188) | 4.35086032 |
| 13 | myelin maintenance (GO:0043217) | 4.28230233 |
| 14 | cholesterol biosynthetic process (GO:0006695) | 4.25763189 |
| 15 | establishment of mitochondrion localization (GO:0051654) | 4.23572261 |
| 16 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.10994933 |
| 17 | vocalization behavior (GO:0071625) | 4.09759528 |
| 18 | cell migration in hindbrain (GO:0021535) | 4.08825522 |
| 19 | oligodendrocyte differentiation (GO:0048709) | 4.04300615 |
| 20 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.99943376 |
| 21 | locomotory exploration behavior (GO:0035641) | 3.99789501 |
| 22 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.97699163 |
| 23 | negative regulation of protein localization to cell surface (GO:2000009) | 3.96919945 |
| 24 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.94733168 |
| 25 | eye photoreceptor cell differentiation (GO:0001754) | 3.92790381 |
| 26 | photoreceptor cell differentiation (GO:0046530) | 3.92790381 |
| 27 | presynaptic membrane organization (GO:0097090) | 3.90742946 |
| 28 | neuron cell-cell adhesion (GO:0007158) | 3.90686985 |
| 29 | response to methylmercury (GO:0051597) | 3.88710234 |
| 30 | glycerophospholipid catabolic process (GO:0046475) | 3.85701783 |
| 31 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.83157824 |
| 32 | apical protein localization (GO:0045176) | 3.80922160 |
| 33 | sterol biosynthetic process (GO:0016126) | 3.73724731 |
| 34 | protein localization to synapse (GO:0035418) | 3.73389489 |
| 35 | layer formation in cerebral cortex (GO:0021819) | 3.73198905 |
| 36 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.72896364 |
| 37 | amyloid precursor protein metabolic process (GO:0042982) | 3.71814350 |
| 38 | dendrite morphogenesis (GO:0048813) | 3.66114303 |
| 39 | presynaptic membrane assembly (GO:0097105) | 3.65845673 |
| 40 | synaptic transmission, glutamatergic (GO:0035249) | 3.62139369 |
| 41 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.61131946 |
| 42 | mitochondrion transport along microtubule (GO:0047497) | 3.61131946 |
| 43 | L-amino acid import (GO:0043092) | 3.60453445 |
| 44 | isoprenoid biosynthetic process (GO:0008299) | 3.60120350 |
| 45 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.59369133 |
| 46 | response to redox state (GO:0051775) | 3.55117742 |
| 47 | astrocyte development (GO:0014002) | 3.54392364 |
| 48 | substantia nigra development (GO:0021762) | 3.54279868 |
| 49 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.52071409 |
| 50 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.50568257 |
| 51 | exploration behavior (GO:0035640) | 3.50120944 |
| 52 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.49438037 |
| 53 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.45795312 |
| 54 | asymmetric protein localization (GO:0008105) | 3.43121470 |
| 55 | auditory behavior (GO:0031223) | 3.41458505 |
| 56 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.41294803 |
| 57 | dopamine biosynthetic process (GO:0042416) | 3.38668045 |
| 58 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.37384971 |
| 59 | response to auditory stimulus (GO:0010996) | 3.31137074 |
| 60 | neuron remodeling (GO:0016322) | 3.30656979 |
| 61 | regulation of synaptic vesicle transport (GO:1902803) | 3.29803176 |
| 62 | axon extension (GO:0048675) | 3.29454028 |
| 63 | glutamate secretion (GO:0014047) | 3.29195053 |
| 64 | establishment of nucleus localization (GO:0040023) | 3.28572527 |
| 65 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.25516783 |
| 66 | glutamate receptor signaling pathway (GO:0007215) | 3.21556394 |
| 67 | positive regulation of synapse assembly (GO:0051965) | 3.20376302 |
| 68 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.18489592 |
| 69 | synapse assembly (GO:0007416) | 3.18173035 |
| 70 | neuronal stem cell maintenance (GO:0097150) | 3.16861420 |
| 71 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.16332491 |
| 72 | limb bud formation (GO:0060174) | 3.15724609 |
| 73 | spinal cord development (GO:0021510) | 3.15439819 |
| 74 | negative regulation of axonogenesis (GO:0050771) | 3.14226972 |
| 75 | adult walking behavior (GO:0007628) | 3.13719794 |
| 76 | regulation of synapse structural plasticity (GO:0051823) | 3.13097126 |
| 77 | dendrite development (GO:0016358) | 3.11113256 |
| 78 | myelination in peripheral nervous system (GO:0022011) | 3.10875697 |
| 79 | peripheral nervous system axon ensheathment (GO:0032292) | 3.10875697 |
| 80 | neuron-neuron synaptic transmission (GO:0007270) | 3.09038556 |
| 81 | central nervous system neuron axonogenesis (GO:0021955) | 3.08168100 |
| 82 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.07764397 |
| 83 | protein palmitoylation (GO:0018345) | 3.06564115 |
| 84 | import into cell (GO:0098657) | 3.05736905 |
| 85 | regulation of growth hormone secretion (GO:0060123) | 3.04283994 |
| 86 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.03693897 |
| 87 | cerebellar granule cell differentiation (GO:0021707) | 3.03432544 |
| 88 | regulation of dopamine metabolic process (GO:0042053) | 3.02943331 |
| 89 | regulation of catecholamine metabolic process (GO:0042069) | 3.02943331 |
| 90 | creatine metabolic process (GO:0006600) | 3.02109109 |
| 91 | axon extension involved in axon guidance (GO:0048846) | 3.01358145 |
| 92 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.01358145 |
| 93 | response to lipoprotein particle (GO:0055094) | 3.00659166 |
| 94 | spinal cord association neuron differentiation (GO:0021527) | 3.00337784 |
| 95 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.97781287 |
| 96 | adhesion of symbiont to host cell (GO:0044650) | 2.97351271 |
| 97 | virion attachment to host cell (GO:0019062) | 2.97351271 |
| 98 | neuromuscular process controlling balance (GO:0050885) | 2.94193577 |
| 99 | retinal ganglion cell axon guidance (GO:0031290) | 2.90753349 |
| 100 | synaptic vesicle endocytosis (GO:0048488) | 2.89289811 |
| 101 | glycosylceramide metabolic process (GO:0006677) | 2.86954741 |
| 102 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.86883664 |
| 103 | magnesium ion transport (GO:0015693) | 2.85065596 |
| 104 | olfactory bulb development (GO:0021772) | 2.84480456 |
| 105 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.84262752 |
| 106 | neuron projection extension (GO:1990138) | 2.82814078 |
| 107 | camera-type eye morphogenesis (GO:0048593) | 2.81731644 |
| 108 | cerebral cortex neuron differentiation (GO:0021895) | 2.81254778 |
| 109 | negative regulation of axon extension (GO:0030517) | 2.80734239 |
| 110 | startle response (GO:0001964) | 2.79996618 |
| 111 | neurotransmitter uptake (GO:0001504) | 2.79959733 |
| 112 | neuron recognition (GO:0008038) | 2.78105380 |
| 113 | axonogenesis (GO:0007409) | 2.77909928 |
| 114 | mechanosensory behavior (GO:0007638) | 2.77149307 |
| 115 | protein neddylation (GO:0045116) | 2.76959799 |
| 116 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.75778467 |
| 117 | regulation of neurotransmitter secretion (GO:0046928) | 2.75524001 |
| 118 | cellular response to epinephrine stimulus (GO:0071872) | 2.74924275 |
| 119 | transmission of nerve impulse (GO:0019226) | 2.74564801 |
| 120 | amino acid import (GO:0043090) | 2.74276216 |
| 121 | limb development (GO:0060173) | 2.74137378 |
| 122 | appendage development (GO:0048736) | 2.74137378 |
| 123 | forebrain neuron differentiation (GO:0021879) | 2.73806334 |
| 124 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.72374519 |
| 125 | membrane assembly (GO:0071709) | 2.71419478 |
| 126 | neuromuscular synaptic transmission (GO:0007274) | 2.71333449 |
| 127 | neuron projection morphogenesis (GO:0048812) | 2.70750587 |
| 128 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.69871813 |
| 129 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.69551218 |
| 130 | GPI anchor biosynthetic process (GO:0006506) | 2.69479329 |
| 131 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.69055722 |
| 132 | enteric nervous system development (GO:0048484) | 2.68851359 |
| 133 | synapse organization (GO:0050808) | 2.68648222 |
| 134 | peptidyl-cysteine modification (GO:0018198) | 2.68579525 |
| 135 | peripheral nervous system development (GO:0007422) | 2.67499900 |
| 136 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.66505729 |
| 137 | positive regulation of growth hormone secretion (GO:0060124) | 2.66501302 |
| 138 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.66399477 |
| 139 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.66399477 |
| 140 | axon development (GO:0061564) | 2.66084661 |
| 141 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.64770430 |
| 142 | regulation of axon guidance (GO:1902667) | 2.64520755 |
| 143 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.64127230 |
| 144 | suckling behavior (GO:0001967) | 2.64028030 |
| 145 | positive regulation of action potential (GO:0045760) | 2.63889556 |
| 146 | membrane tubulation (GO:0097320) | 2.63800817 |
| 147 | GPI anchor metabolic process (GO:0006505) | 2.63149026 |
| 148 | ganglion development (GO:0061548) | 2.63036207 |
| 149 | cellular potassium ion homeostasis (GO:0030007) | 2.62886394 |
| 150 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.59296213 |
| 151 | neural nucleus development (GO:0048857) | 2.54310080 |
| 152 | glial cell development (GO:0021782) | 2.53938148 |
| 153 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.53343018 |
| 154 | response to epinephrine (GO:0071871) | 2.53164499 |
| 155 | neuronal action potential propagation (GO:0019227) | 2.50096397 |
| 156 | axonal fasciculation (GO:0007413) | 2.49930127 |
| 157 | negative regulation of synaptic transmission (GO:0050805) | 2.49681052 |
| 158 | positive regulation of actin filament depolymerization (GO:0030836) | 2.48927577 |
| 159 | neuronal ion channel clustering (GO:0045161) | 2.45959896 |
| 160 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.45171303 |
| 161 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.45171303 |
| 162 | ceramide biosynthetic process (GO:0046513) | 2.42302819 |
| 163 | cellular response to monoamine stimulus (GO:0071868) | 2.40759453 |
| 164 | cellular response to catecholamine stimulus (GO:0071870) | 2.40759453 |
| 165 | negative regulation of acute inflammatory response (GO:0002674) | 2.40387237 |
| 166 | regulation of lipoprotein metabolic process (GO:0050746) | 2.39674187 |
| 167 | nucleotide transmembrane transport (GO:1901679) | 2.38117249 |
| 168 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.37843989 |
| 169 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.37413270 |
| 170 | microtubule polymerization or depolymerization (GO:0031109) | 2.37236088 |
| 171 | glial cell differentiation (GO:0010001) | 2.36615497 |
| 172 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.35765308 |
| 173 | amyloid precursor protein catabolic process (GO:0042987) | 2.34762143 |
| 174 | dendritic spine morphogenesis (GO:0060997) | 2.34650852 |
| 175 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.33722184 |
| 176 | synaptic vesicle exocytosis (GO:0016079) | 2.33422605 |
| 177 | central nervous system myelination (GO:0022010) | 10.1506298 |
| 178 | axon ensheathment in central nervous system (GO:0032291) | 10.1506298 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.48786135 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.15195059 |
| 3 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.68867511 |
| 4 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.68177211 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.67103017 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.60977000 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.54288599 |
| 8 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.36142324 |
| 9 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.30731767 |
| 10 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.27891623 |
| 11 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.25907985 |
| 12 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.25546080 |
| 13 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.25546080 |
| 14 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.21761387 |
| 15 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.21700633 |
| 16 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.20487130 |
| 17 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.19256694 |
| 18 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.11136184 |
| 19 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.11126708 |
| 20 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.09759511 |
| 21 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.07643134 |
| 22 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.04308928 |
| 23 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.03545709 |
| 24 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.02024790 |
| 25 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.93856016 |
| 26 | VDR_22108803_ChIP-Seq_LS180_Human | 1.92497724 |
| 27 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.88365188 |
| 28 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.84450642 |
| 29 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.83717203 |
| 30 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.80894732 |
| 31 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.78730664 |
| 32 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.72854337 |
| 33 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.71552822 |
| 34 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.70249958 |
| 35 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.69484060 |
| 36 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.64867166 |
| 37 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.63326509 |
| 38 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.60823587 |
| 39 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.59138429 |
| 40 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.59138429 |
| 41 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.58533499 |
| 42 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.57144716 |
| 43 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.56468793 |
| 44 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.54947457 |
| 45 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.52827047 |
| 46 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.51235256 |
| 47 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.50116779 |
| 48 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.49597501 |
| 49 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.48432747 |
| 50 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.47894875 |
| 51 | P300_19829295_ChIP-Seq_ESCs_Human | 1.41262912 |
| 52 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.39206777 |
| 53 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.38083936 |
| 54 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.36066858 |
| 55 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.33833184 |
| 56 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.32819065 |
| 57 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.31943966 |
| 58 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.31421083 |
| 59 | FUS_26573619_Chip-Seq_HEK293_Human | 1.30417190 |
| 60 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.29768775 |
| 61 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.29132148 |
| 62 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.26583662 |
| 63 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.24119727 |
| 64 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.23471907 |
| 65 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.22156130 |
| 66 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.20046304 |
| 67 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.19609885 |
| 68 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.19562738 |
| 69 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.19542614 |
| 70 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.17097097 |
| 71 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.16882747 |
| 72 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.16742301 |
| 73 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.15240173 |
| 74 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.15167569 |
| 75 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.14156425 |
| 76 | AR_19668381_ChIP-Seq_PC3_Human | 1.13467948 |
| 77 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.13097504 |
| 78 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.12923021 |
| 79 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.11084317 |
| 80 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.10592499 |
| 81 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.09633434 |
| 82 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.08900667 |
| 83 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.08628295 |
| 84 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.07697215 |
| 85 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07165959 |
| 86 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.06933129 |
| 87 | STAT3_23295773_ChIP-Seq_U87_Human | 1.05622418 |
| 88 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.05477731 |
| 89 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.03437324 |
| 90 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.03437324 |
| 91 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.03373054 |
| 92 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.02665704 |
| 93 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.02489643 |
| 94 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.01993010 |
| 95 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.01729597 |
| 96 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.01685025 |
| 97 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.00734882 |
| 98 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.00550049 |
| 99 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.00144894 |
| 100 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.99988015 |
| 101 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.99135738 |
| 102 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.98974999 |
| 103 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.98153117 |
| 104 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.97712678 |
| 105 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.97363038 |
| 106 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.96993966 |
| 107 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.96408571 |
| 108 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.95938328 |
| 109 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.95786068 |
| 110 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.95594312 |
| 111 | TCF4_23295773_ChIP-Seq_U87_Human | 0.95293761 |
| 112 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94734218 |
| 113 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.94463997 |
| 114 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.94402510 |
| 115 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.94216232 |
| 116 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.93980128 |
| 117 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.93665740 |
| 118 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.93403856 |
| 119 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.93263290 |
| 120 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.93202566 |
| 121 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.92771307 |
| 122 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.92056702 |
| 123 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.91989917 |
| 124 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.91446001 |
| 125 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.91309403 |
| 126 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.91242355 |
| 127 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.90366864 |
| 128 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.90228734 |
| 129 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.90174212 |
| 130 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.88112320 |
| 131 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.87138980 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000920_abnormal_myelination | 4.42095229 |
| 2 | MP0003880_abnormal_central_pattern | 4.23752535 |
| 3 | MP0004270_analgesia | 3.23419920 |
| 4 | MP0001529_abnormal_vocalization | 3.18576043 |
| 5 | MP0003950_abnormal_plasma_membrane | 2.95128883 |
| 6 | MP0001905_abnormal_dopamine_level | 2.84890580 |
| 7 | MP0005171_absent_coat_pigmentation | 2.62523023 |
| 8 | MP0004859_abnormal_synaptic_plasticity | 2.61894816 |
| 9 | MP0004742_abnormal_vestibular_system | 2.58034241 |
| 10 | MP0002272_abnormal_nervous_system | 2.57149001 |
| 11 | MP0003787_abnormal_imprinting | 2.41066337 |
| 12 | MP0002064_seizures | 2.39637217 |
| 13 | MP0001486_abnormal_startle_reflex | 2.32276961 |
| 14 | MP0003690_abnormal_glial_cell | 2.30957152 |
| 15 | MP0000778_abnormal_nervous_system | 2.28070476 |
| 16 | MP0003329_amyloid_beta_deposits | 2.27924059 |
| 17 | MP0005423_abnormal_somatic_nervous | 2.23213946 |
| 18 | MP0004885_abnormal_endolymph | 2.14429155 |
| 19 | MP0003635_abnormal_synaptic_transmissio | 2.10566306 |
| 20 | MP0002653_abnormal_ependyma_morphology | 2.10108442 |
| 21 | MP0009046_muscle_twitch | 2.08085195 |
| 22 | MP0003634_abnormal_glial_cell | 2.06974330 |
| 23 | MP0002734_abnormal_mechanical_nocicepti | 2.06678954 |
| 24 | MP0009745_abnormal_behavioral_response | 2.04228789 |
| 25 | MP0003136_yellow_coat_color | 2.03957205 |
| 26 | MP0004142_abnormal_muscle_tone | 2.02024137 |
| 27 | MP0006292_abnormal_olfactory_placode | 1.96063800 |
| 28 | MP0005409_darkened_coat_color | 1.92376840 |
| 29 | MP0003121_genomic_imprinting | 1.86188962 |
| 30 | MP0002822_catalepsy | 1.77002332 |
| 31 | MP0002572_abnormal_emotion/affect_behav | 1.76373191 |
| 32 | MP0001970_abnormal_pain_threshold | 1.74636926 |
| 33 | MP0001485_abnormal_pinna_reflex | 1.72804805 |
| 34 | MP0001440_abnormal_grooming_behavior | 1.70847062 |
| 35 | MP0005499_abnormal_olfactory_system | 1.70287633 |
| 36 | MP0005394_taste/olfaction_phenotype | 1.70287633 |
| 37 | MP0002063_abnormal_learning/memory/cond | 1.67522471 |
| 38 | MP0002733_abnormal_thermal_nociception | 1.66023213 |
| 39 | MP0001968_abnormal_touch/_nociception | 1.65707901 |
| 40 | MP0000569_abnormal_digit_pigmentation | 1.63414736 |
| 41 | MP0002735_abnormal_chemical_nociception | 1.61454971 |
| 42 | MP0003632_abnormal_nervous_system | 1.55725748 |
| 43 | MP0002229_neurodegeneration | 1.53822080 |
| 44 | MP0002736_abnormal_nociception_after | 1.52258568 |
| 45 | MP0010678_abnormal_skin_adnexa | 1.47757921 |
| 46 | MP0005410_abnormal_fertilization | 1.45361438 |
| 47 | MP0000955_abnormal_spinal_cord | 1.44601237 |
| 48 | MP0003123_paternal_imprinting | 1.44136119 |
| 49 | MP0003861_abnormal_nervous_system | 1.42848686 |
| 50 | MP0006276_abnormal_autonomic_nervous | 1.40670221 |
| 51 | MP0002882_abnormal_neuron_morphology | 1.39937594 |
| 52 | MP0002067_abnormal_sensory_capabilities | 1.37293752 |
| 53 | MP0004381_abnormal_hair_follicle | 1.36648772 |
| 54 | MP0000462_abnormal_digestive_system | 1.36103297 |
| 55 | MP0000383_abnormal_hair_follicle | 1.35411713 |
| 56 | MP0004134_abnormal_chest_morphology | 1.35122429 |
| 57 | MP0005386_behavior/neurological_phenoty | 1.31546084 |
| 58 | MP0004924_abnormal_behavior | 1.31546084 |
| 59 | MP0005623_abnormal_meninges_morphology | 1.30142142 |
| 60 | MP0008789_abnormal_olfactory_epithelium | 1.29237847 |
| 61 | MP0003631_nervous_system_phenotype | 1.29068780 |
| 62 | MP0002066_abnormal_motor_capabilities/c | 1.23793013 |
| 63 | MP0001963_abnormal_hearing_physiology | 1.23064421 |
| 64 | MP0005645_abnormal_hypothalamus_physiol | 1.22327514 |
| 65 | MP0005551_abnormal_eye_electrophysiolog | 1.22091599 |
| 66 | MP0001293_anophthalmia | 1.22045523 |
| 67 | MP0001501_abnormal_sleep_pattern | 1.21518697 |
| 68 | MP0002184_abnormal_innervation | 1.18968492 |
| 69 | MP0000049_abnormal_middle_ear | 1.18541892 |
| 70 | MP0001346_abnormal_lacrimal_gland | 1.17044745 |
| 71 | MP0000566_synostosis | 1.16317407 |
| 72 | MP0002752_abnormal_somatic_nervous | 1.16017040 |
| 73 | MP0008569_lethality_at_weaning | 1.14687131 |
| 74 | MP0008260_abnormal_autophagy | 1.13614774 |
| 75 | MP0000604_amyloidosis | 1.13505736 |
| 76 | MP0003890_abnormal_embryonic-extraembry | 1.10669734 |
| 77 | MP0002233_abnormal_nose_morphology | 1.10486881 |
| 78 | MP0003633_abnormal_nervous_system | 1.08955088 |
| 79 | MP0004043_abnormal_pH_regulation | 1.07340535 |
| 80 | MP0002557_abnormal_social/conspecific_i | 1.05099258 |
| 81 | MP0005187_abnormal_penis_morphology | 1.04926103 |
| 82 | MP0005248_abnormal_Harderian_gland | 1.04719474 |
| 83 | MP0002638_abnormal_pupillary_reflex | 1.03906923 |
| 84 | MP0005646_abnormal_pituitary_gland | 1.02908918 |
| 85 | MP0003938_abnormal_ear_development | 1.01840802 |
| 86 | MP0003119_abnormal_digestive_system | 1.01606859 |
| 87 | MP0005451_abnormal_body_composition | 1.01493221 |
| 88 | MP0000762_abnormal_tongue_morphology | 1.01278355 |
| 89 | MP0003283_abnormal_digestive_organ | 0.99332789 |
| 90 | MP0000537_abnormal_urethra_morphology | 0.97091384 |
| 91 | MP0010030_abnormal_orbit_morphology | 0.96992253 |
| 92 | MP0001177_atelectasis | 0.94438104 |
| 93 | MP0000428_abnormal_craniofacial_morphol | 0.93726341 |
| 94 | MP0001299_abnormal_eye_distance/ | 0.92202767 |
| 95 | MP0000026_abnormal_inner_ear | 0.88932134 |
| 96 | MP0000647_abnormal_sebaceous_gland | 0.87304124 |
| 97 | MP0002152_abnormal_brain_morphology | 0.86243340 |
| 98 | MP0005195_abnormal_posterior_eye | 0.84438312 |
| 99 | MP0009379_abnormal_foot_pigmentation | 0.83813450 |
| 100 | MP0002081_perinatal_lethality | 0.83782334 |
| 101 | MP0002697_abnormal_eye_size | 0.82795366 |
| 102 | MP0005377_hearing/vestibular/ear_phenot | 0.81301430 |
| 103 | MP0003878_abnormal_ear_physiology | 0.81301430 |
| 104 | MP0002295_abnormal_pulmonary_circulatio | 0.80573486 |
| 105 | MP0003937_abnormal_limbs/digits/tail_de | 0.80539058 |
| 106 | MP0001188_hyperpigmentation | 0.80341960 |
| 107 | MP0004811_abnormal_neuron_physiology | 0.79533885 |
| 108 | MP0001664_abnormal_digestion | 0.78005548 |
| 109 | MP0002116_abnormal_craniofacial_bone | 0.77665123 |
| 110 | MP0004858_abnormal_nervous_system | 0.77054723 |
| 111 | MP0000579_abnormal_nail_morphology | 0.76861241 |
| 112 | MP0010386_abnormal_urinary_bladder | 0.75555459 |
| 113 | MP0009250_abnormal_appendicular_skeleto | 0.75463731 |
| 114 | MP0002069_abnormal_eating/drinking_beha | 0.74829476 |
| 115 | MP0003755_abnormal_palate_morphology | 0.74684165 |
| 116 | MP0003942_abnormal_urinary_system | 0.74148538 |
| 117 | MP0000747_muscle_weakness | 0.72680599 |
| 118 | MP0003122_maternal_imprinting | 0.71325750 |
| 119 | MP0000372_irregular_coat_pigmentation | 0.71131039 |
| 120 | MP0000631_abnormal_neuroendocrine_gland | 0.70367476 |
| 121 | MP0004147_increased_porphyrin_level | 0.70157638 |
| 122 | MP0001851_eye_inflammation | 0.66782236 |
| 123 | MP0004133_heterotaxia | 0.65882461 |
| 124 | MP0002938_white_spotting | 0.65813756 |
| 125 | MP0002796_impaired_skin_barrier | 0.65341297 |
| 126 | MP0002751_abnormal_autonomic_nervous | 0.64822012 |
| 127 | MP0001340_abnormal_eyelid_morphology | 0.63838822 |
| 128 | MP0001984_abnormal_olfaction | 0.62739961 |
| 129 | MP0001502_abnormal_circadian_rhythm | 0.61991386 |
| 130 | MP0000467_abnormal_esophagus_morphology | 0.61861790 |
| 131 | MP0001348_abnormal_lacrimal_gland | 0.61567522 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 5.81146717 |
| 2 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 5.81146717 |
| 3 | Parakeratosis (HP:0001036) | 5.77947595 |
| 4 | Neurofibrillary tangles (HP:0002185) | 5.53972088 |
| 5 | Abnormality of the corticospinal tract (HP:0002492) | 4.32922168 |
| 6 | Sensory axonal neuropathy (HP:0003390) | 4.13905163 |
| 7 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 4.11242922 |
| 8 | Cerebral inclusion bodies (HP:0100314) | 4.10758571 |
| 9 | Peripheral hypomyelination (HP:0007182) | 4.01870626 |
| 10 | Cerebral hypomyelination (HP:0006808) | 3.89251718 |
| 11 | Hepatoblastoma (HP:0002884) | 3.81567652 |
| 12 | Supranuclear gaze palsy (HP:0000605) | 3.57392863 |
| 13 | Drooling (HP:0002307) | 3.45697909 |
| 14 | Onion bulb formation (HP:0003383) | 3.36290580 |
| 15 | Myokymia (HP:0002411) | 3.32820600 |
| 16 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.31145659 |
| 17 | Limb dystonia (HP:0002451) | 3.26360509 |
| 18 | Excessive salivation (HP:0003781) | 3.21947165 |
| 19 | Cortical dysplasia (HP:0002539) | 3.19216984 |
| 20 | Alacrima (HP:0000522) | 3.19070172 |
| 21 | Spastic gait (HP:0002064) | 3.08857113 |
| 22 | Ankle clonus (HP:0011448) | 3.00954407 |
| 23 | Insidious onset (HP:0003587) | 2.90214046 |
| 24 | Termporal pattern (HP:0011008) | 2.90214046 |
| 25 | Abnormal auditory evoked potentials (HP:0006958) | 2.90159474 |
| 26 | Leukodystrophy (HP:0002415) | 2.90122276 |
| 27 | Dysmetria (HP:0001310) | 2.89457483 |
| 28 | Retinal dysplasia (HP:0007973) | 2.80124054 |
| 29 | Vitreoretinal degeneration (HP:0000655) | 2.78279394 |
| 30 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.77540925 |
| 31 | Akinesia (HP:0002304) | 2.77509613 |
| 32 | Polyphagia (HP:0002591) | 2.75677075 |
| 33 | Febrile seizures (HP:0002373) | 2.74160892 |
| 34 | Short 4th metacarpal (HP:0010044) | 2.66575726 |
| 35 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.66575726 |
| 36 | Intention tremor (HP:0002080) | 2.62042987 |
| 37 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.61552082 |
| 38 | Abnormality of glycolysis (HP:0004366) | 2.61175055 |
| 39 | Increased serum pyruvate (HP:0003542) | 2.61175055 |
| 40 | Absent septum pellucidum (HP:0001331) | 2.53851700 |
| 41 | Abnormality of the 4th metacarpal (HP:0010012) | 2.52409787 |
| 42 | Decreased lacrimation (HP:0000633) | 2.51702332 |
| 43 | Hypoplastic pelvis (HP:0008839) | 2.47187200 |
| 44 | Inappropriate behavior (HP:0000719) | 2.45442969 |
| 45 | Scanning speech (HP:0002168) | 2.44962511 |
| 46 | Pheochromocytoma (HP:0002666) | 2.41652878 |
| 47 | Slow saccadic eye movements (HP:0000514) | 2.40991376 |
| 48 | Autoamputation (HP:0001218) | 2.38707389 |
| 49 | Cutaneous finger syndactyly (HP:0010554) | 2.37852413 |
| 50 | Patchy hypopigmentation of hair (HP:0011365) | 2.36452128 |
| 51 | Abnormal eating behavior (HP:0100738) | 2.36350613 |
| 52 | Hyperventilation (HP:0002883) | 2.35642158 |
| 53 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.32863153 |
| 54 | Progressive cerebellar ataxia (HP:0002073) | 2.32333967 |
| 55 | Oligodactyly (hands) (HP:0001180) | 2.31817105 |
| 56 | Abnormality of the septum pellucidum (HP:0007375) | 2.29478255 |
| 57 | Focal motor seizures (HP:0011153) | 2.29411277 |
| 58 | White forelock (HP:0002211) | 2.25848150 |
| 59 | Anteriorly placed anus (HP:0001545) | 2.25224177 |
| 60 | Clumsiness (HP:0002312) | 2.24656763 |
| 61 | Cutaneous syndactyly (HP:0012725) | 2.24500147 |
| 62 | Morphological abnormality of the inner ear (HP:0011390) | 2.21113663 |
| 63 | Anomalous pulmonary venous return (HP:0010772) | 2.18034439 |
| 64 | Abnormality of the lower motor neuron (HP:0002366) | 2.16986979 |
| 65 | Stridor (HP:0010307) | 2.14211393 |
| 66 | Generalized tonic-clonic seizures (HP:0002069) | 2.13067041 |
| 67 | Abnormality of the labia minora (HP:0012880) | 2.10880336 |
| 68 | Absent/shortened dynein arms (HP:0200106) | 2.10668218 |
| 69 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.10668218 |
| 70 | Partial agenesis of the corpus callosum (HP:0001338) | 2.10362689 |
| 71 | Neuroendocrine neoplasm (HP:0100634) | 2.09797091 |
| 72 | Septo-optic dysplasia (HP:0100842) | 2.08842004 |
| 73 | Optic nerve hypoplasia (HP:0000609) | 2.08405953 |
| 74 | Adrenal hypoplasia (HP:0000835) | 2.08392345 |
| 75 | Hypoplasia of the iris (HP:0007676) | 2.08343090 |
| 76 | CNS hypomyelination (HP:0003429) | 2.07643569 |
| 77 | Thickened helices (HP:0000391) | 2.06973044 |
| 78 | Oligodactyly (HP:0012165) | 2.05737806 |
| 79 | Absent speech (HP:0001344) | 2.04221602 |
| 80 | Vaginal atresia (HP:0000148) | 2.03692057 |
| 81 | Spastic paraparesis (HP:0002313) | 2.03557600 |
| 82 | Turricephaly (HP:0000262) | 2.03520929 |
| 83 | Aplasia involving bones of the extremities (HP:0009825) | 2.01893627 |
| 84 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.01893627 |
| 85 | Aplasia of the phalanges of the hand (HP:0009802) | 2.01893627 |
| 86 | Lower limb muscle weakness (HP:0007340) | 2.00614040 |
| 87 | Foot dorsiflexor weakness (HP:0009027) | 1.98683904 |
| 88 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.96910997 |
| 89 | Split foot (HP:0001839) | 1.96654855 |
| 90 | Genital tract atresia (HP:0001827) | 1.95818394 |
| 91 | Acute necrotizing encephalopathy (HP:0006965) | 1.95399559 |
| 92 | Myelomeningocele (HP:0002475) | 1.95371799 |
| 93 | Metabolic alkalosis (HP:0200114) | 1.94958931 |
| 94 | Disinhibition (HP:0000734) | 1.94450007 |
| 95 | Coronal craniosynostosis (HP:0004440) | 1.94110669 |
| 96 | Abnormality of the ischium (HP:0003174) | 1.93874872 |
| 97 | High anterior hairline (HP:0009890) | 1.93078442 |
| 98 | Agitation (HP:0000713) | 1.92778604 |
| 99 | Abnormality of salivation (HP:0100755) | 1.92373423 |
| 100 | Sleep apnea (HP:0010535) | 1.92175527 |
| 101 | Growth hormone deficiency (HP:0000824) | 1.91586258 |
| 102 | Increased circulating renin level (HP:0000848) | 1.91495820 |
| 103 | Aqueductal stenosis (HP:0002410) | 1.90829559 |
| 104 | Hypoplasia of the corpus callosum (HP:0002079) | 1.90502248 |
| 105 | Agnosia (HP:0010524) | 1.89819658 |
| 106 | Amyotrophic lateral sclerosis (HP:0007354) | 1.88929569 |
| 107 | Dialeptic seizures (HP:0011146) | 1.88686809 |
| 108 | Cerebral hemorrhage (HP:0001342) | 1.88643855 |
| 109 | Abnormality of the diencephalon (HP:0010662) | 1.87972863 |
| 110 | Methylmalonic acidemia (HP:0002912) | 1.86630892 |
| 111 | Abnormality of the pulmonary veins (HP:0011718) | 1.86582198 |
| 112 | Cupped ear (HP:0000378) | 1.86398485 |
| 113 | Apathy (HP:0000741) | 1.85972945 |
| 114 | Genetic anticipation (HP:0003743) | 1.83459356 |
| 115 | Mutism (HP:0002300) | 1.82581622 |
| 116 | Erythroderma (HP:0001019) | 1.82090280 |
| 117 | Decreased motor nerve conduction velocity (HP:0003431) | 1.81374540 |
| 118 | Anophthalmia (HP:0000528) | 1.81373200 |
| 119 | Premature skin wrinkling (HP:0100678) | 1.81182177 |
| 120 | Nephronophthisis (HP:0000090) | 1.80667972 |
| 121 | Colon cancer (HP:0003003) | 1.80417034 |
| 122 | Poor speech (HP:0002465) | 1.79725444 |
| 123 | Megalencephaly (HP:0001355) | 1.79484779 |
| 124 | Gait imbalance (HP:0002141) | 1.79456932 |
| 125 | Epileptic encephalopathy (HP:0200134) | 1.79218593 |
| 126 | Abnormal ciliary motility (HP:0012262) | 1.77992445 |
| 127 | Esophageal atresia (HP:0002032) | 1.77301213 |
| 128 | Renal Fanconi syndrome (HP:0001994) | 1.76905961 |
| 129 | Atonic seizures (HP:0010819) | 1.76764596 |
| 130 | 3-Methylglutaconic aciduria (HP:0003535) | 1.75803684 |
| 131 | Hemiplegia (HP:0002301) | 1.75115154 |
| 132 | Focal seizures (HP:0007359) | 1.74511902 |
| 133 | Abnormality of the foot musculature (HP:0001436) | 1.74215851 |
| 134 | Action tremor (HP:0002345) | 1.73782206 |
| 135 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.73385197 |
| 136 | Abnormality of binocular vision (HP:0011514) | 1.72843692 |
| 137 | Diplopia (HP:0000651) | 1.72843692 |
| 138 | Intellectual disability, moderate (HP:0002342) | 1.72613724 |
| 139 | Hemiparesis (HP:0001269) | 1.72435750 |
| 140 | Diminished motivation (HP:0000745) | 1.72363986 |
| 141 | Intestinal atresia (HP:0011100) | 1.72196550 |
| 142 | Protruding tongue (HP:0010808) | 1.71701742 |
| 143 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.70684715 |
| 144 | Diminished movement (HP:0002374) | 1.70531023 |
| 145 | Steppage gait (HP:0003376) | 1.70360616 |
| 146 | Spastic tetraplegia (HP:0002510) | 1.69537524 |
| 147 | Stereotypic behavior (HP:0000733) | 1.68118213 |
| 148 | Conical tooth (HP:0000698) | 1.67973872 |
| 149 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.67507361 |
| 150 | Omphalocele (HP:0001539) | 1.66000894 |
| 151 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.65732542 |
| 152 | Specific learning disability (HP:0001328) | 1.65415695 |
| 153 | Broad long bones (HP:0005622) | 1.64669492 |
| 154 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.64537299 |
| 155 | Bowel incontinence (HP:0002607) | 1.64459811 |
| 156 | Neonatal short-limb short stature (HP:0008921) | 1.64074449 |
| 157 | Broad thumb (HP:0011304) | 1.63880181 |
| 158 | Broad phalanges of the hand (HP:0009768) | 1.62775479 |
| 159 | Trigonocephaly (HP:0000243) | 1.62660623 |
| 160 | Amblyopia (HP:0000646) | 1.62535415 |
| 161 | Epileptiform EEG discharges (HP:0011182) | 1.61995288 |
| 162 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.61770620 |
| 163 | Distal sensory impairment (HP:0002936) | 1.61419154 |
| 164 | Urinary urgency (HP:0000012) | 1.61047605 |
| 165 | Absence seizures (HP:0002121) | 1.60635220 |
| 166 | Broad finger (HP:0001500) | 1.60603963 |
| 167 | Broad-based gait (HP:0002136) | 1.60348405 |
| 168 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.60342484 |
| 169 | Hypoplasia of the brainstem (HP:0002365) | 1.60342484 |
| 170 | Exotropia (HP:0000577) | 1.59874558 |
| 171 | Abnormality of the antihelix (HP:0009738) | 1.59787363 |
| 172 | Tracheomalacia (HP:0002779) | 1.59654033 |
| 173 | Hypomagnesemia (HP:0002917) | 1.59568206 |
| 174 | Paraparesis (HP:0002385) | 1.58490679 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 5.37352551 |
| 2 | OXSR1 | 3.77646817 |
| 3 | MAPKAPK5 | 2.95853965 |
| 4 | EPHB1 | 2.80145790 |
| 5 | PBK | 2.68869007 |
| 6 | PKN1 | 2.54087522 |
| 7 | BCR | 2.49811663 |
| 8 | MET | 2.48800602 |
| 9 | CASK | 2.29224894 |
| 10 | CDK19 | 2.26471010 |
| 11 | EPHB2 | 2.25896982 |
| 12 | WNK4 | 2.18757958 |
| 13 | LIMK1 | 2.10439898 |
| 14 | UHMK1 | 1.88454225 |
| 15 | SIK2 | 1.88390691 |
| 16 | CSNK1G3 | 1.81931210 |
| 17 | WNK1 | 1.75409329 |
| 18 | PNCK | 1.72559796 |
| 19 | TNIK | 1.69870373 |
| 20 | FGR | 1.69401449 |
| 21 | PRPF4B | 1.66650601 |
| 22 | CAMK2B | 1.64872605 |
| 23 | NEK6 | 1.61385352 |
| 24 | NTRK1 | 1.56718002 |
| 25 | MARK1 | 1.53788870 |
| 26 | CSNK1A1L | 1.47859605 |
| 27 | MST4 | 1.47225261 |
| 28 | ROCK2 | 1.46183114 |
| 29 | FGFR2 | 1.45497844 |
| 30 | CAMK2D | 1.43086060 |
| 31 | CSNK1G2 | 1.35659064 |
| 32 | EPHA4 | 1.33891661 |
| 33 | SGK223 | 1.33662063 |
| 34 | SGK494 | 1.33662063 |
| 35 | CSNK1G1 | 1.32214088 |
| 36 | CAMK1D | 1.30385893 |
| 37 | SGK2 | 1.24121465 |
| 38 | CAMKK1 | 1.23176529 |
| 39 | KSR1 | 1.23156972 |
| 40 | DYRK2 | 1.18936904 |
| 41 | MAP2K4 | 1.17275447 |
| 42 | BMPR1B | 1.12839530 |
| 43 | PAK6 | 1.10939708 |
| 44 | PIK3CA | 1.10253509 |
| 45 | CLK1 | 1.06429038 |
| 46 | TYRO3 | 1.05183019 |
| 47 | DAPK2 | 1.04915480 |
| 48 | TESK2 | 1.04697363 |
| 49 | WNK3 | 1.04416327 |
| 50 | CAMK2A | 1.01754723 |
| 51 | MAPK13 | 1.00937044 |
| 52 | LATS2 | 0.98527106 |
| 53 | MARK2 | 0.97384599 |
| 54 | KSR2 | 0.97024596 |
| 55 | CAMK2G | 0.95566139 |
| 56 | STK11 | 0.94973758 |
| 57 | CDK14 | 0.93747974 |
| 58 | ADRBK2 | 0.93365032 |
| 59 | DDR2 | 0.92303039 |
| 60 | CAMK1 | 0.92113223 |
| 61 | CDK5 | 0.92098503 |
| 62 | MST1R | 0.89777321 |
| 63 | BRD4 | 0.89739942 |
| 64 | MAP3K2 | 0.88649386 |
| 65 | NME1 | 0.88557474 |
| 66 | MAP2K2 | 0.87914436 |
| 67 | ICK | 0.87381535 |
| 68 | SGK3 | 0.86373198 |
| 69 | MKNK2 | 0.84931104 |
| 70 | NTRK2 | 0.84236814 |
| 71 | CDK15 | 0.82991473 |
| 72 | MAPK15 | 0.82114963 |
| 73 | CDK18 | 0.80432020 |
| 74 | PRKCE | 0.80383045 |
| 75 | DYRK1B | 0.78986418 |
| 76 | NTRK3 | 0.78115149 |
| 77 | ARAF | 0.76479099 |
| 78 | CAMK4 | 0.76030797 |
| 79 | MOS | 0.75479455 |
| 80 | CDK11A | 0.75468769 |
| 81 | MAP3K10 | 0.75362767 |
| 82 | GRK5 | 0.74106856 |
| 83 | RIPK1 | 0.73389061 |
| 84 | CAMKK2 | 0.70018660 |
| 85 | PRKCZ | 0.69460768 |
| 86 | PHKG2 | 0.69333340 |
| 87 | PHKG1 | 0.69333340 |
| 88 | PAK3 | 0.68241583 |
| 89 | MKNK1 | 0.68057656 |
| 90 | SGK1 | 0.66156514 |
| 91 | GRK7 | 0.65882977 |
| 92 | LATS1 | 0.64907908 |
| 93 | PLK2 | 0.64380208 |
| 94 | PRKCQ | 0.64061490 |
| 95 | PINK1 | 0.61615562 |
| 96 | MAP3K9 | 0.56719874 |
| 97 | DYRK3 | 0.56332169 |
| 98 | RPS6KA5 | 0.56089458 |
| 99 | PRKCH | 0.55572837 |
| 100 | MAPK10 | 0.53827672 |
| 101 | MUSK | 0.53444310 |
| 102 | ERBB2 | 0.52226799 |
| 103 | PTK2B | 0.51707991 |
| 104 | FYN | 0.51486615 |
| 105 | MAP3K4 | 0.51079461 |
| 106 | MAP2K7 | 0.50926886 |
| 107 | PRKG1 | 0.47374056 |
| 108 | ERBB4 | 0.46206317 |
| 109 | PRKD1 | 0.45732719 |
| 110 | MINK1 | 0.45276867 |
| 111 | FES | 0.45227355 |
| 112 | PDGFRB | 0.44866974 |
| 113 | RPS6KA3 | 0.44212826 |
| 114 | PRKD3 | 0.44107054 |
| 115 | IRAK2 | 0.44070148 |
| 116 | CSNK1D | 0.43054238 |
| 117 | NEK2 | 0.42656464 |
| 118 | DAPK3 | 0.42289899 |
| 119 | CSNK1E | 0.41998267 |
| 120 | RPS6KA2 | 0.41515986 |
| 121 | EPHA3 | 0.41417983 |
| 122 | DYRK1A | 0.40573678 |
| 123 | PDGFRA | 0.39453824 |
| 124 | CSNK1A1 | 0.39340427 |
| 125 | PDPK1 | 0.35421836 |
| 126 | ALK | 0.35054503 |
| 127 | BMPR2 | 0.34994439 |
| 128 | GSK3B | 0.34623683 |
| 129 | STK16 | 0.33320783 |
| 130 | PRKACB | 0.33085405 |
| 131 | YES1 | 0.32808423 |
| 132 | MAP3K13 | 0.32520278 |
| 133 | MAP3K12 | 0.31766595 |
| 134 | PRKACA | 0.31090414 |
| 135 | PLK4 | 0.30323401 |
| 136 | MAPK8 | 0.30289902 |
| 137 | CDK3 | 0.30283412 |
| 138 | TRPM7 | 0.29871130 |
| 139 | GSK3A | 0.28730612 |
| 140 | PRKCG | 0.28598291 |
| 141 | ADRBK1 | 0.28525446 |
| 142 | CAMK1G | 0.28486889 |
| 143 | RET | 0.27801055 |
| 144 | GRK1 | 0.27718653 |
| 145 | ROCK1 | 0.27441103 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 4.98252112 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.99922048 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.66771406 |
| 4 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.89405269 |
| 5 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.85536416 |
| 6 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.44992158 |
| 7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.44360670 |
| 8 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 2.02667070 |
| 9 | Axon guidance_Homo sapiens_hsa04360 | 1.97627827 |
| 10 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.90884833 |
| 11 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.89564593 |
| 12 | Parkinsons disease_Homo sapiens_hsa05012 | 1.77162786 |
| 13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.72964116 |
| 14 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.65674020 |
| 15 | Alzheimers disease_Homo sapiens_hsa05010 | 1.63317275 |
| 16 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.62437805 |
| 17 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.59410586 |
| 18 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.58922770 |
| 19 | GABAergic synapse_Homo sapiens_hsa04727 | 1.58586313 |
| 20 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.56042454 |
| 21 | Nicotine addiction_Homo sapiens_hsa05033 | 1.55007971 |
| 22 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.52686308 |
| 23 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.49561710 |
| 24 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.48968042 |
| 25 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.43585396 |
| 26 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.41791197 |
| 27 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.41772218 |
| 28 | Long-term depression_Homo sapiens_hsa04730 | 1.41116538 |
| 29 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.35954415 |
| 30 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.34920129 |
| 31 | Morphine addiction_Homo sapiens_hsa05032 | 1.34493936 |
| 32 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.34436933 |
| 33 | Protein export_Homo sapiens_hsa03060 | 1.32198544 |
| 34 | Cocaine addiction_Homo sapiens_hsa05030 | 1.27503645 |
| 35 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.26625301 |
| 36 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.22997092 |
| 37 | Circadian entrainment_Homo sapiens_hsa04713 | 1.19546116 |
| 38 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.18935844 |
| 39 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.18810486 |
| 40 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.18073842 |
| 41 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.13925881 |
| 42 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.13639940 |
| 43 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.11209168 |
| 44 | Histidine metabolism_Homo sapiens_hsa00340 | 1.10936716 |
| 45 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.07204293 |
| 46 | Colorectal cancer_Homo sapiens_hsa05210 | 1.04487477 |
| 47 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.03869068 |
| 48 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.03202661 |
| 49 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.02962807 |
| 50 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.02163662 |
| 51 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.01210293 |
| 52 | Salivary secretion_Homo sapiens_hsa04970 | 1.00732018 |
| 53 | Huntingtons disease_Homo sapiens_hsa05016 | 1.00271197 |
| 54 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.97507563 |
| 55 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.97387585 |
| 56 | Mineral absorption_Homo sapiens_hsa04978 | 0.95783143 |
| 57 | Phototransduction_Homo sapiens_hsa04744 | 0.94601653 |
| 58 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.90740632 |
| 59 | Taste transduction_Homo sapiens_hsa04742 | 0.89619201 |
| 60 | Tight junction_Homo sapiens_hsa04530 | 0.89394961 |
| 61 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.88628234 |
| 62 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.88419760 |
| 63 | Phagosome_Homo sapiens_hsa04145 | 0.88365096 |
| 64 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.86297427 |
| 65 | Endometrial cancer_Homo sapiens_hsa05213 | 0.86134326 |
| 66 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.84123882 |
| 67 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.81943408 |
| 68 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.81413827 |
| 69 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.81117739 |
| 70 | Glioma_Homo sapiens_hsa05214 | 0.80239208 |
| 71 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.79174018 |
| 72 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.78767294 |
| 73 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.77605160 |
| 74 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.73320213 |
| 75 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.73226914 |
| 76 | Gap junction_Homo sapiens_hsa04540 | 0.72539059 |
| 77 | Adherens junction_Homo sapiens_hsa04520 | 0.72292711 |
| 78 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.72083100 |
| 79 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.71980445 |
| 80 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.71599376 |
| 81 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.70928320 |
| 82 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.70829562 |
| 83 | Renin secretion_Homo sapiens_hsa04924 | 0.69930965 |
| 84 | Olfactory transduction_Homo sapiens_hsa04740 | 0.68226292 |
| 85 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.66991537 |
| 86 | Endocytosis_Homo sapiens_hsa04144 | 0.64869401 |
| 87 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.64850037 |
| 88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.64173538 |
| 89 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.64073734 |
| 90 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.63154219 |
| 91 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.60657728 |
| 92 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.59975549 |
| 93 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.59760188 |
| 94 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.59331882 |
| 95 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.58950738 |
| 96 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.57678993 |
| 97 | Lysosome_Homo sapiens_hsa04142 | 0.56446524 |
| 98 | Long-term potentiation_Homo sapiens_hsa04720 | 0.56334263 |
| 99 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.55538551 |
| 100 | Alcoholism_Homo sapiens_hsa05034 | 0.54643540 |
| 101 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.53766747 |
| 102 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.52896620 |
| 103 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.52059909 |
| 104 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.51827757 |
| 105 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.51192737 |
| 106 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.50309654 |
| 107 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.49421792 |
| 108 | Pathways in cancer_Homo sapiens_hsa05200 | 0.49407235 |
| 109 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.48445968 |
| 110 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.46558604 |
| 111 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.46336441 |
| 112 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.45838549 |
| 113 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.45694291 |
| 114 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.45429567 |
| 115 | Insulin secretion_Homo sapiens_hsa04911 | 0.45306590 |
| 116 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.44673461 |
| 117 | Melanogenesis_Homo sapiens_hsa04916 | 0.43383516 |
| 118 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.43197985 |
| 119 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.42952434 |
| 120 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.42882043 |
| 121 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.42677511 |
| 122 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.42343104 |
| 123 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.42329452 |
| 124 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.42009862 |
| 125 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.41484938 |
| 126 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.38742811 |
| 127 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.37125373 |
| 128 | Prion diseases_Homo sapiens_hsa05020 | 0.36639799 |
| 129 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.35976150 |
| 130 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.35757793 |
| 131 | Salmonella infection_Homo sapiens_hsa05132 | 0.35338282 |
| 132 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.34205596 |
| 133 | Malaria_Homo sapiens_hsa05144 | 0.33606888 |
| 134 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.33318409 |
| 135 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.32108265 |
| 136 | * Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27116607 |
| 137 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.26969775 |
| 138 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.26579869 |

